IRS struggles with device tax

Share this article:

The 2.3% medical device tax that went into effect last year is not garnering the revenue the IRS anticipated, and the Associated Press reports that the key reason appears to be follow-through. A Treasury report covered by the AP says a key issue is that the IRS is having trouble identifying just who owes it money.

The tax is supposed to apply to medical devices professionals use, such as pacemakers, and the expectation was that the levy would provide $29 billion by 2023, but collection rates indicate it will only collect around 75% of this if current collection practices continue.

Device manufacturers have been working to get the tax repealed, but the AP notes that eliminating the tax would leave a revenue hole for which there is currently no proposed replacement.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Genentech shift could prove costly for hospitals

Genentech will use specialty distributors rather than wholesalers, hospitals pharmacy directors have learned.

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies